New York State Common Retirement Fund’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-90
| Closed | -$1K | – | 3385 |
|
2024
Q2 | $1K | Sell |
90
-6,300
| -99% | -$70K | ﹤0.01% | 3334 |
|
2024
Q1 | $33K | Hold |
6,390
| – | – | ﹤0.01% | 3077 |
|
2023
Q4 | $33K | Sell |
6,390
-24
| -0.4% | -$124 | ﹤0.01% | 3087 |
|
2023
Q3 | $101K | Sell |
6,414
-8,905
| -58% | -$140K | ﹤0.01% | 2720 |
|
2023
Q2 | $298K | Sell |
15,319
-1,722
| -10% | -$33.5K | ﹤0.01% | 2329 |
|
2023
Q1 | $483K | Sell |
17,041
-9,523
| -36% | -$270K | ﹤0.01% | 2193 |
|
2022
Q4 | $776K | Buy |
26,564
+18,174
| +217% | +$531K | ﹤0.01% | 2100 |
|
2022
Q3 | $222K | Buy |
8,390
+13
| +0.2% | +$344 | ﹤0.01% | 2733 |
|
2022
Q2 | $372K | Sell |
8,377
-28
| -0.3% | -$1.24K | ﹤0.01% | 2501 |
|
2022
Q1 | $416K | Buy |
8,405
+7
| +0.1% | +$346 | ﹤0.01% | 2487 |
|
2021
Q4 | $428K | Sell |
8,398
-32
| -0.4% | -$1.63K | ﹤0.01% | 2514 |
|
2021
Q3 | $470K | Sell |
8,430
-2,154
| -20% | -$120K | ﹤0.01% | 2501 |
|
2021
Q2 | $453K | Buy |
10,584
+84
| +0.8% | +$3.6K | ﹤0.01% | 2657 |
|
2021
Q1 | $438K | Sell |
10,500
-1,100
| -9% | -$45.9K | ﹤0.01% | 2519 |
|
2020
Q4 | $540K | Hold |
11,600
| – | – | ﹤0.01% | 2316 |
|
2020
Q3 | $493K | Hold |
11,600
| – | – | ﹤0.01% | 2221 |
|
2020
Q2 | $557K | Buy |
11,600
+2,100
| +22% | +$101K | ﹤0.01% | 2151 |
|
2020
Q1 | $437K | Hold |
9,500
| – | – | ﹤0.01% | 2114 |
|
2019
Q4 | $571K | Hold |
9,500
| – | – | ﹤0.01% | 2235 |
|
2019
Q3 | $537K | Sell |
9,500
-11,075
| -54% | -$626K | ﹤0.01% | 2294 |
|
2019
Q2 | $1.15M | Buy |
20,575
+5,939
| +41% | +$331K | ﹤0.01% | 1946 |
|
2019
Q1 | $739K | Hold |
14,636
| – | – | ﹤0.01% | 2119 |
|
2018
Q4 | $590K | Sell |
14,636
-56,997
| -80% | -$2.3M | ﹤0.01% | 2200 |
|
2018
Q3 | $4.97M | Buy |
71,633
+8,422
| +13% | +$584K | 0.01% | 1272 |
|
2018
Q2 | $4.78M | Sell |
63,211
-1,256
| -2% | -$95K | 0.01% | 1281 |
|
2018
Q1 | $3.4M | Buy |
64,467
+2,234
| +4% | +$118K | ﹤0.01% | 1372 |
|
2017
Q4 | $3.32M | Buy |
62,233
+11,213
| +22% | +$599K | ﹤0.01% | 1397 |
|
2017
Q3 | $3.04M | Sell |
51,020
-483
| -0.9% | -$28.8K | ﹤0.01% | 1423 |
|
2017
Q2 | $4.06M | Buy |
51,503
+15,002
| +41% | +$1.18M | 0.01% | 1354 |
|
2017
Q1 | $3.03M | Buy |
36,501
+19,034
| +109% | +$1.58M | ﹤0.01% | 1464 |
|
2016
Q4 | $1.39M | Buy |
17,467
+8,067
| +86% | +$640K | ﹤0.01% | 1878 |
|
2016
Q3 | $658K | Buy |
9,400
+500
| +6% | +$35K | ﹤0.01% | 2188 |
|
2016
Q2 | $345K | Hold |
8,900
| – | – | ﹤0.01% | 2450 |
|
2016
Q1 | $360K | Sell |
8,900
-3,134
| -26% | -$127K | ﹤0.01% | 2397 |
|
2015
Q4 | $1.07M | Buy |
12,034
+600
| +5% | +$53.2K | ﹤0.01% | 1934 |
|
2015
Q3 | $846K | Buy |
11,434
+2,530
| +28% | +$187K | ﹤0.01% | 2041 |
|
2015
Q2 | $720K | Buy |
8,904
+6,093
| +217% | +$493K | ﹤0.01% | 2360 |
|
2015
Q1 | $118K | Buy |
+2,811
| New | +$118K | ﹤0.01% | 2210 |
|